Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
for Obesity or Overweight
42 locations incl. Pelham
Sponsor: Amgen
Sex: All·Age: 18 - 99
Code: NCT07575399·Phase 3·Recruiting·Listed May 2026